Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATFurniture, Fixtures and OtherLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShort-Term Debt repayments
Ratios

Plus Therapeutics (PSTV) R&D In Process (2017)

Plus Therapeutics (PSTV) has disclosed R&D In Process for 1 consecutive years, with $1.7 million as the latest value for Q1 2017.

  • Quarterly R&D In Process changed N/A to $1.7 million in Q1 2017 from the year-ago period, while the trailing twelve-month figure was $1.7 million through Dec 2017, changed N/A year-over-year, with the annual reading at $250000.0 for FY2021, 67.99% down from the prior year.
  • R&D In Process for Q1 2017 was $1.7 million at Plus Therapeutics.
  • The five-year high for R&D In Process was $1.7 million in Q1 2017, with the low at $1.7 million in Q1 2017.